{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06120842",
            "orgStudyIdInfo": {
                "id": "SGP-003"
            },
            "organization": {
                "fullName": "SpyGlass Pharma, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solution",
            "officialTitle": "A Prospective, Multicenter, Randomized, Masked, Controlled Study to Evaluate the Safety, Efficacy, and Dose-response of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Maleate Ophthalmic Solution, USP, 0.5%",
            "acronym": "Tigris",
            "therapeuticArea": [
                "Cardiovascular",
                "Ophthalmology"
            ],
            "study": "evaluation-of-the-bimatoprost-implant-system-used-in-combination-with-the-spyglass-intraocular-lens-compared-to-timolol-ophthalmic-solution"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-11",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-10-13",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-08",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-06",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-11-01",
            "studyFirstSubmitQcDate": "2023-11-01",
            "studyFirstPostDateStruct": {
                "date": "2023-11-07",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-11-08",
            "lastUpdatePostDateStruct": {
                "date": "2023-11-13",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "SpyGlass Pharma, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": true,
            "isUnapprovedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "This trial is a randomized study to evaluate and compare two doses of the Bimatoprost Implant System used in combination with the SpyGlass IOL to Timolol Ophthalmic Solution in participants with mild to moderate open-angle glaucoma or ocular hypertension undergoing cataract surgery."
        },
        "conditionsModule": {
            "conditions": [
                "Cataract",
                "Glaucoma",
                "Ocular Hypertension"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 140,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Bimatoprost Implant System (High Dose) / IOL Combination",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Bimatoprost Implant System (High Dose)",
                        "Device: SpyGlass IOL"
                    ]
                },
                {
                    "label": "Bimatoprost Implant System (Low Dose) / IOL Combination",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Bimatoprost Implant System (Low Dose)",
                        "Device: SpyGlass IOL"
                    ]
                },
                {
                    "label": "Timolol Maleate Ophthalmic Solution 0.5%",
                    "type": "ACTIVE_COMPARATOR",
                    "interventionNames": [
                        "Drug: Timolol Maleate Ophthalmic Solution, 0.5%",
                        "Device: Commercially Available Aspheric Monofocal Non-Yellow Chromophore IOL"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Bimatoprost Implant System (High Dose)",
                    "description": "Bimatoprost Implant System (High Dose) used in combination with the SpyGlass IOL",
                    "armGroupLabels": [
                        "Bimatoprost Implant System (High Dose) / IOL Combination"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Bimatoprost Implant System (Low Dose)",
                    "description": "Bimatoprost Implant System (Low Dose) used in combination with the SpyGlass IOL",
                    "armGroupLabels": [
                        "Bimatoprost Implant System (Low Dose) / IOL Combination"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Timolol Maleate Ophthalmic Solution, 0.5%",
                    "description": "Timolol Maleate Ophthalmic Solution 0.5% BID",
                    "armGroupLabels": [
                        "Timolol Maleate Ophthalmic Solution 0.5%"
                    ]
                },
                {
                    "type": "DEVICE",
                    "name": "Commercially Available Aspheric Monofocal Non-Yellow Chromophore IOL",
                    "description": "Commercially Available Aspheric Monofocal Non-Yellow Chromophore Intraocular Lens",
                    "armGroupLabels": [
                        "Timolol Maleate Ophthalmic Solution 0.5%"
                    ]
                },
                {
                    "type": "DEVICE",
                    "name": "SpyGlass IOL",
                    "description": "SpyGlass Intraocular Lens",
                    "armGroupLabels": [
                        "Bimatoprost Implant System (High Dose) / IOL Combination",
                        "Bimatoprost Implant System (Low Dose) / IOL Combination"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Mean IOP Reduction from Baseline (mmHg)",
                    "description": "Time matched mean IOP reduction from Baseline (mmHg) in the study eyes at all the individual IOP timepoints",
                    "timeFrame": "Weeks 2 and 6, and Month 3"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Mean IOP",
                    "description": "Time matched mean IOP (mmHg) at Weeks 2 and 6 and Months 3, 6, 12, 18, 24, 27, 30, 33, and 36",
                    "timeFrame": "Weeks 2 and 6 and Months 3, 6, 12, 18, 24, 27, 30, 33, and 36"
                },
                {
                    "measure": "Mean IOP Change from Baseline",
                    "description": "Time matched mean IOP change from Baseline (mmHg) at Months 6, 12, 18, 24, 27, 30, 33, and 36",
                    "timeFrame": "Months 6, 12, 18, 24, 27, 30, 33, and 36"
                },
                {
                    "measure": "Time to postoperative introduction of IOP-lowering medications",
                    "description": "Time (Days) to postoperative introduction of IOP-lowering medications (IOP-lowering medications other than the study treatments)",
                    "timeFrame": "Total Study Period of 36 Months"
                },
                {
                    "measure": "Number of IOP-lowering medications introduced postoperatively",
                    "description": "Number of IOP-lowering medications introduced postoperatively (N) at Weeks 2 and 6, and Months 3, 6, 12, 18, 24, 27, 30, 33, and 36",
                    "timeFrame": "Total Study Period of 36 Months"
                },
                {
                    "measure": "Proportion of eyes achieving BCDVA 20/40 or better",
                    "description": "Snellen Equivalent",
                    "timeFrame": "Months 3, 6, and 12"
                },
                {
                    "measure": "Manifest refraction spherical equivalent",
                    "description": "Manifest refraction spherical equivalent (MRSE)",
                    "timeFrame": "Month 3"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Number and Rates of Adverse Events",
                    "timeFrame": "Total Study Period of 36 Months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of mild to moderate open-angle glaucoma or ocular hypertension\n* Planned removal of cataract\n* Female participants of childbearing potential must have a negative urine pregnancy test at the baseline visit and agree to the use of contraception\n\nExclusion Criteria:\n\n* Uncontrolled systemic disease\n* History of incisional/refractive corneal surgery\n* Any glaucoma diagnosis other than OHT, open-angle, pseudoexfoliation, or pigmentary glaucoma\n* History of incisional glaucoma surgery or intraocular injections\n* Other ocular diseases, pathology, or conditions",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "22 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Chris Hafner",
                    "role": "CONTACT",
                    "phone": "18184421564",
                    "email": "chris@spyglasspharma.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Chris Hafner",
                    "affiliation": "SpyGlass Pharma, Inc.",
                    "role": "STUDY_CHAIR"
                }
            ],
            "locations": [
                {
                    "facility": "Arizona Advanced Eye Research Institute",
                    "status": "RECRUITING",
                    "city": "Glendale",
                    "state": "Arizona",
                    "zip": "85306",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Pat Dawson",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.53865,
                        "lon": -112.18599
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "SpyGlass Pharma Website",
                    "url": "https://www.spyglasspharma.com/"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002386",
                    "term": "Cataract"
                },
                {
                    "id": "D000009798",
                    "term": "Ocular Hypertension"
                }
            ],
            "ancestors": [
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                },
                {
                    "id": "D000007905",
                    "term": "Lens Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5638",
                    "name": "Cataract",
                    "asFound": "Cataract",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10024",
                    "name": "Hypertension",
                    "relevance": "LOW"
                },
                {
                    "id": "M9013",
                    "name": "Glaucoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M12731",
                    "name": "Ocular Hypertension",
                    "asFound": "Ocular Hypertension",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10917",
                    "name": "Lens Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000013999",
                    "term": "Timolol"
                },
                {
                    "id": "D000069580",
                    "term": "Bimatoprost"
                },
                {
                    "id": "D000009883",
                    "term": "Ophthalmic Solutions"
                }
            ],
            "ancestors": [
                {
                    "id": "D000019999",
                    "term": "Pharmaceutical Solutions"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000319",
                    "term": "Adrenergic beta-Antagonists"
                },
                {
                    "id": "D000018674",
                    "term": "Adrenergic Antagonists"
                },
                {
                    "id": "D000018663",
                    "term": "Adrenergic Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000000889",
                    "term": "Anti-Arrhythmia Agents"
                },
                {
                    "id": "D000000959",
                    "term": "Antihypertensive Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M12814",
                    "name": "Ophthalmic Solutions",
                    "asFound": "Anxiety",
                    "relevance": "HIGH"
                },
                {
                    "id": "M16757",
                    "name": "Timolol",
                    "asFound": "Insulin Sensitivity",
                    "relevance": "HIGH"
                },
                {
                    "id": "M473",
                    "name": "Bimatoprost",
                    "asFound": "Resolution",
                    "relevance": "HIGH"
                },
                {
                    "id": "M245808",
                    "name": "Maleic acid",
                    "relevance": "LOW"
                },
                {
                    "id": "M3671",
                    "name": "Adrenergic beta-Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20746",
                    "name": "Adrenergic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20755",
                    "name": "Adrenergic Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4213",
                    "name": "Anti-Arrhythmia Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4277",
                    "name": "Antihypertensive Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AnArAg",
                    "name": "Anti-Arrhythmia Agents"
                },
                {
                    "abbrev": "AnAg",
                    "name": "Antihypertensive Agents"
                }
            ]
        }
    },
    "hasResults": false
}